These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10893002)

  • 1. Enhanced pulmonary pathology in cotton rats upon challenge after immunization with inactivated parainfluenza virus 3 vaccines.
    Ottolini MG; Porter DD; Hemming VG; Prince GA
    Viral Immunol; 2000; 13(2):231-6. PubMed ID: 10893002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization.
    Murphy BR; Sotnikov AV; Lawrence LA; Banks SM; Prince GA
    Vaccine; 1990 Oct; 8(5):497-502. PubMed ID: 2251875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults.
    Tang RS; Spaete RR; Thompson MW; MacPhail M; Guzzetta JM; Ryan PC; Reisinger K; Chandler P; Hilty M; Walker RE; Gomez MM; Losonsky GA
    Vaccine; 2008 Nov; 26(50):6373-82. PubMed ID: 18822334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3-6 months after immunization.
    Hildreth SW; Baggs RR; Brownstein DG; Castleman WL; Paradiso PR
    Vaccine; 1993; 11(6):615-8. PubMed ID: 8322482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of inactivated vaccines prepared with parainfluenza viruses type 1 and type 3, administered experimentally by nasal or oral route.
    Petrescu AL; Petica M; Bârnaure F; Athanasiu P
    Rom J Virol; 1998; 49(1-4):97-115. PubMed ID: 10892431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIV-3 vaccine National Institutes of Health/Aviron.
    Jones T
    Curr Opin Investig Drugs; 2001 Jul; 2(7):890-2. PubMed ID: 11757785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of respiratory syncytial virus (RSV) infected cells by in situ hybridization in the lungs of cotton rats immunized with formalin-inactivated virus or purified RSV F and G glycoprotein subunit vaccine and challenged with RSV.
    Murphy BR; Prince GA; Lawrence LA; Croen KD; Collins PL
    Virus Res; 1990 Jun; 16(2):153-62. PubMed ID: 2385958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of lung injury in cotton rats immunized with formalin-inactivated respiratory syncytial virus.
    Piedra PA; Faden HS; Camussi G; Wong DT; Ogra PL
    Vaccine; 1989 Feb; 7(1):34-8. PubMed ID: 2655343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine.
    Prince GA; Curtis SJ; Yim KC; Porter DD
    J Gen Virol; 2001 Dec; 82(Pt 12):2881-2888. PubMed ID: 11714962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of vaccines for parainfluenza virus infections.
    Sato M; Wright PF
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S123-5. PubMed ID: 18820572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children.
    Belshe RB; Newman FK; Anderson EL; Wright PF; Karron RA; Tollefson S; Henderson FW; Meissner HC; Madhi S; Roberton D; Marshall H; Loh R; Sly P; Murphy B; Tatem JM; Randolph V; Hackell J; Gruber W; Tsai TF
    J Infect Dis; 2004 Dec; 190(12):2096-103. PubMed ID: 15551207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged.
    Yim KC; Cragin RP; Boukhvalova MS; Blanco JC; Hamlin ME; Boivin G; Porter DD; Prince GA
    Vaccine; 2007 Jun; 25(27):5034-40. PubMed ID: 17543425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.
    Homa FL; Brideau RJ; Lehman DJ; Thomsen DR; Olmsted RA; Wathen MW
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1995-9. PubMed ID: 8397289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus).
    Prince GA; Prieels JP; Slaoui M; Porter DD
    Lab Invest; 1999 Nov; 79(11):1385-92. PubMed ID: 10576209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inactivated parainfluenza virus type 3 vaccine: the influence of vaccination regime on the response of calves and their subsequent resistance to challenge.
    Probert M; Stott EJ; Thomas LH; Collins AP; Jebbett J
    Res Vet Sci; 1978 Mar; 24(2):222-7. PubMed ID: 206935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model.
    Yim K; Miles B; Zinsou R; Prince G; Boukhvalova M
    Vaccine; 2012 Feb; 30(7):1291-6. PubMed ID: 22210139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of parainfluenza-3 virus challenge on cell-mediated immune function in parainfluenza-3 vaccinated and non-vaccinated calves.
    Adair BM; Bradford HE; Bryson DG; Foster JC; Mcnulty MS
    Res Vet Sci; 2000 Apr; 68(2):197-9. PubMed ID: 10756139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant type 5 adenoviruses expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection.
    Breker-Klassen MM; Yoo D; Mittal SK; Sorden SD; Haines DM; Babiuk LA
    J Virol; 1995 Jul; 69(7):4308-15. PubMed ID: 7769692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nasal secretion and serum antibody response of lambs following vaccination and aerosol challenge with parainfluenza 3 virus.
    Smith WD
    Res Vet Sci; 1975 Jul; 19(1):56-62. PubMed ID: 168628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children.
    Gomez M; Mufson MA; Dubovsky F; Knightly C; Zeng W; Losonsky G
    Pediatr Infect Dis J; 2009 Jul; 28(7):655-8. PubMed ID: 19483659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.